Showing 1 - 3 results of 3 for search 'Marcel P.M. Stokkel', query time: 0.02s Refine Results
  1. 1
    Pretreatment PET dissemination features as biomarkers for survival outcomes in melanoma patients treated with immune-checkpoint inhibitors

    Pretreatment PET dissemination features as biomarkers for survival outcomes in melanoma patients treated with immune-checkpoint inhibitors by Hanna Saadani, Else A. Aalbersberg, Mutamba T. Kayembe, John B.A.G. Haanen, Otto S. Hoekstra, Ronald Boellaard, Marcel P.M. Stokkel

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Impact of routine FDG-PET/CT on locoregional treatment decisions in breast cancer patients receiving preoperative systemic therapy

    Impact of routine FDG-PET/CT on locoregional treatment decisions in breast cancer patients receiving preoperative systemic therapy by Jetske L.B. Gunster, A. Marjolein Schrijver, Frederieke H. van Duijnhoven, Marcel P.M. Stokkel, Corrie A.M. Marijnen, Astrid N. Scholten

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Metabolic parameters on baseline and early [18F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma

    Metabolic parameters on baseline and early [18F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma by Bernies van der Hiel, Berlinda J. de Wit - van der Veen, Alfons J. M. van den Eertwegh, Wouter V. Vogel, Marcel P. M. Stokkel, Marta Lopez-Yurda, Ronald Boellaard, Ellen W. Kapiteijn, Geke A. P. Hospers, Maureen J. B. Aarts, Filip Y. F. L. de Vos, Marye J. Boers-Sonderen, Astrid A. M. van der Veldt, Jan Willem B. de Groot, John B. A. G. Haanen

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: